Omesec-RD Capsule is a combination pharmaceutical formulation containing Domperidone 10mg and Omeprazole 20mg, designed for the effective management of gastrointestinal disorders. Domperidone, a peripheral dopamine D2 receptor antagonist, facilitates gastric motility and accelerates gastric emptying, thereby alleviating symptoms such as nausea, vomiting, and bloating associated with delayed gastric emptying or gastroparesis. Omeprazole, a proton pump inhibitor, suppresses gastric acid secretion by irreversibly inhibiting the H+/K+ ATPase enzyme system in the gastric parietal cells, providing symptomatic relief and promoting healing in acid-related conditions such as gastroesophageal reflux disease (GERD), peptic ulcers, and erosive esophagitis. The synergistic action of Domperidone and Omeprazole in Omesec-RD Capsule offers comprehensive management by addressing both motility and acid secretion abnormalities. This combination is particularly beneficial in patients presenting with reflux symptoms accompanied by delayed gastric emptying. Omesec-RD should be administered as prescribed by a healthcare professional, with consideration of contraindications such as hypersensitivity to components, and caution in patients with cardiac arrhythmias or hepatic impairment. Adverse effects may include headache, dry mouth, abdominal discomfort, or rarely, extrapyramidal symptoms. Regular monitoring and adherence to prescribed dosage enhance therapeutic outcomes and minimize potential risks.